VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
ZOZO, Inc. vs Abbott Laboratories
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
ZOZO, Inc.
3092 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Abbott Laboratories
ABT · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Abbott Laboratories's moat claims, evidence, and risks.
View ABT analysisComparison highlights
- Moat score gap: Abbott Laboratories leads (64 / 100 vs 63 / 100 for ZOZO, Inc.).
- Segment focus: ZOZO, Inc. has 5 segments (71.3% in ZOZOTOWN Business); Abbott Laboratories has 7 segments (26.7% in Cardiovascular & Electrophysiology Devices).
- Moat breadth: ZOZO, Inc. has 5 moat types across 3 domains; Abbott Laboratories has 10 across 3.
Primary market context
ZOZO, Inc.
ZOZOTOWN Business
Japan online fashion marketplace and resale (ZOZOTOWN)
Japan
Consumers (buyers) and fashion brands/retailers (sellers/tenants)
Marketplace operator + retailer (mix of consignment, inventory retail, and used sales)
71.3%
Abbott Laboratories
Cardiovascular & Electrophysiology Devices
Cardiovascular, electrophysiology, rhythm management, structural heart and heart failure devices
Global
Hospitals, ambulatory surgery centers, cardiologists/electrophysiologists
Implantable device manufacturer
26.7%
Side-by-side metrics
Moat coverage
Shared moat types
ZOZO, Inc. strengths
Abbott Laboratories strengths
Segment mix
ZOZO, Inc. segments
Full profile >ZOZOTOWN Business
Oligopoly
LY Corporation Commerce
Competitive
BtoB business
Competitive
Advertising business (ZOZOAD / WEAR reach monetization)
Monopoly
Others (platform services, shipping/settlement fees, and options)
Monopoly
Abbott Laboratories segments
Full profile >Established Pharmaceutical Products
Competitive
Diagnostic Products
Oligopoly
Pediatric Nutrition
Oligopoly
Adult Nutrition
Oligopoly
Diabetes Care (CGM & glucose monitoring)
Duopoly
Cardiovascular & Electrophysiology Devices
Oligopoly
Neuromodulation Devices
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.